| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
bromodomain containing 1 | 0.644 | 0.654 | 1.00 |
|
disease | 0.500 | None | 0.800 | 1 | 1 | 2006 | 2019 | ||||||||
|
solute carrier family 1 member 1 | 0.561 | 0.654 | 8.7E-06 |
|
disease | 0.500 | None | 1.000 | 1 | 2 | 2001 | 2018 | ||||||||
|
neuregulin 1 | 0.464 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.948 | 1 | 1 | 2002 | 2020 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
disease | 0.500 | None | 1.000 | 1 | 1 | 1997 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 1 | 7 | 1996 | 2017 | ||||||||
|
VRK serine/threonine kinase 2 | 0.722 | 0.269 | 1.6E-11 |
|
disease | 0.480 | None | 1.000 | 7 | 6 | 2009 | 2019 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.480 | None | 0.500 | 3 | 5 | 1993 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 5 subunit | 0.593 | 0.577 | 2.1E-06 |
|
disease | 0.480 | None | 1.000 | 1 | 1 | 2011 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.470 | None | 0.500 | 3 | 8 | 2002 | 2019 | ||||||||
|
nudE neurodevelopment protein 1 | 0.608 | 0.462 | 6.7E-03 |
|
disease | 0.470 | None | 1.000 | 1 | 1 | 2007 | 2019 | ||||||||
|
MIR137 host gene | 0.839 | 0.038 |
|
disease | 0.460 | None | 0.500 | 9 | 6 | 2011 | 2019 | |||||||||
|
discs large MAGUK scaffold protein 2 | 0.670 | 0.577 | 0.71 |
|
disease | 0.460 | None | 0.750 | 3 | 1 | 2003 | 2019 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
disease | 0.460 | None | 1.000 | 1 | 1 | 2009 | 2019 | ||||||||
|
gamma-aminobutyric acid type B receptor subunit 1 | 0.587 | 0.769 | 1.00 |
|
disease | 0.460 | None | 1.000 | 1 | 1 | 2002 | 2017 | ||||||||
|
cyclin and CBS domain divalent metal cation transport mediator 2 | 0.641 | 0.346 | 1.00 |
|
disease | 0.450 | None | 1.000 | 5 | 3 | 2011 | 2019 | ||||||||
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 0.530 | 0.692 | 0.98 |
|
disease | 0.450 | None | 0.500 | 2 | 1 | 2008 | 2019 | ||||||||
|
FYN proto-oncogene, Src family tyrosine kinase | 0.556 | 0.731 | 0.99 |
|
disease | 0.450 | None | 0.500 | 2 | 1 | 2000 | 2019 | ||||||||
|
tetraspanin 18 | 0.792 | 0.231 | 8.2E-02 |
|
disease | 0.450 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
mitotic arrest deficient 1 like 1 | 0.570 | 0.731 | 6.8E-16 |
|
disease | 0.440 | None | 1.000 | 11 | 9 | 2011 | 2020 | ||||||||
|
t-SNARE domain containing 1 | 0.861 | 0.077 | 9.6E-07 |
|
disease | 0.440 | None | 1.000 | 10 | 6 | 2013 | 2019 | ||||||||
|
inter-alpha-trypsin inhibitor heavy chain 3 | 0.769 | 0.231 | 1.5E-13 |
|
disease | 0.440 | None | 1.000 | 6 | 3 | 2011 | 2019 | ||||||||
|
polybromo 1 | 0.566 | 0.615 | 1.00 |
|
disease | 0.440 | None | 1.000 | 2 | 1 | 2011 | 2020 | ||||||||
|
neurotrophic receptor tyrosine kinase 3 | 0.522 | 0.692 | 1.00 |
|
disease | 0.440 | None | 1.000 | 1 | 1 | 1998 | 2015 | ||||||||
|
mitochondrial pyruvate carrier 2 | 0.743 | 0.308 | 0.64 |
|
disease | 0.440 | None | 0.800 | 1 | 1 | 2011 | 2018 | ||||||||
|
calcium voltage-gated channel auxiliary subunit beta 2 | 0.659 | 0.538 | 2.7E-06 |
|
disease | 0.430 | None | 1.000 | 10 | 5 | 2013 | 2019 |